Wolfgang Weilermann
Chairman at TRADE & VALUE AG
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Andreas Beyer | M | 56 | 3 years | |
| Sebastian Kern | M | 60 | 10 years | |
| Justus Linker | M | - | - | |
| Oliver Dornisch | M | 56 |
Dornisch Research AG
| 23 years |
| Steve Schwarzfischer | M | - |
Excalibur Capital AG
 Excalibur Capital AG Financial ConglomeratesFinance Excalibur Capital AG engages in the acquisition, holding, and sale of securities and precious metals. The company was founded on November 24, 1998 and is headquartered in Oldenburg, Germany. | 22 years |
| Heinfried Hahn | M | 54 |
Excalibur Capital AG
Excalibur Capital AG Financial ConglomeratesFinance Excalibur Capital AG engages in the acquisition, holding, and sale of securities and precious metals. The company was founded on November 24, 1998 and is headquartered in Oldenburg, Germany. | - |
| Marco Herack | M | 44 | - | |
| Uwe Jännert | M | 50 | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Stephan Wehselau | M | 55 |
NascaCell Technologies AG
 NascaCell Technologies AG Pharmaceuticals: MajorHealth Technology Nascacell Technologies Ag. offers improved, broadened and accelerated modern drug discovery. The company provides services like new generation of biomolecules with its Aptamer and Microbody technologies. Support is given to the customers in the areas of drug discovery and target validation. The company was founded in 2003 and is headquartered in Munich, Germany. | 5 years |
| Veit Madaus | M | 50 | 6 years | |
| Manfred Zoltobrocki | M | - |
NascaCell Technologies AG
NascaCell Technologies AG Pharmaceuticals: MajorHealth Technology Nascacell Technologies Ag. offers improved, broadened and accelerated modern drug discovery. The company provides services like new generation of biomolecules with its Aptamer and Microbody technologies. Support is given to the customers in the areas of drug discovery and target validation. The company was founded in 2003 and is headquartered in Munich, Germany. | - |
| Jörg-Christian Rehling | M | - | 10 years | |
| Michael Blind | M | - |
NascaCell Technologies AG
NascaCell Technologies AG Pharmaceuticals: MajorHealth Technology Nascacell Technologies Ag. offers improved, broadened and accelerated modern drug discovery. The company provides services like new generation of biomolecules with its Aptamer and Microbody technologies. Support is given to the customers in the areas of drug discovery and target validation. The company was founded in 2003 and is headquartered in Munich, Germany. | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Germany | 13 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Wolfgang Weilermann
- Personal Network
